Yifeng Pharmacy (603939) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.055x

Based on the latest financial reports, Yifeng Pharmacy (603939) has a cash flow conversion efficiency ratio of 0.055x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥641.93 Million ≈ $93.93 Million USD) by net assets (CN¥11.66 Billion ≈ $1.71 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Yifeng Pharmacy - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how Yifeng Pharmacy's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 603939 total debt and obligations for a breakdown of total debt and financial obligations.

Yifeng Pharmacy Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Yifeng Pharmacy ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
AIXTRON SE (UNSP.ADR/2) F:AIX2	0.088x
CJ Corp KO:001040	0.102x
Antar Chile SN:ANTARCHILE	0.005x
Enphase Energy Inc NASDAQ:ENPH	0.044x
AIXTRON SE XETRA:AIXA	0.088x
Group 1 Automotive Inc NYSE:GPI	0.046x
Gubre Fabrikalari TAS IS:GUBRF	0.108x
Terns Pharmaceuticals Inc NASDAQ:TERN	-0.070x

Annual Cash Flow Conversion Efficiency for Yifeng Pharmacy (2011–2024)

The table below shows the annual cash flow conversion efficiency of Yifeng Pharmacy from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see Yifeng Pharmacy (603939) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥11.39 Billion ≈ $1.67 Billion	CN¥4.22 Billion ≈ $617.70 Million	0.370x	-17.00%
2023-12-31	CN¥10.45 Billion ≈ $1.53 Billion	CN¥4.66 Billion ≈ $682.38 Million	0.446x	+3.86%
2022-12-31	CN¥9.12 Billion ≈ $1.33 Billion	CN¥3.92 Billion ≈ $573.66 Million	0.430x	+57.21%
2021-12-31	CN¥7.86 Billion ≈ $1.15 Billion	CN¥2.15 Billion ≈ $314.61 Million	0.273x	+18.34%
2020-12-31	CN¥5.78 Billion ≈ $846.10 Million	CN¥1.34 Billion ≈ $195.45 Million	0.231x	+12.93%
2019-12-31	CN¥4.71 Billion ≈ $689.07 Million	CN¥963.23 Million ≈ $140.95 Million	0.205x	+67.01%
2018-12-31	CN¥4.17 Billion ≈ $610.18 Million	CN¥510.71 Million ≈ $74.73 Million	0.122x	+22.77%
2017-12-31	CN¥3.18 Billion ≈ $465.28 Million	CN¥317.20 Million ≈ $46.42 Million	0.100x	+112.11%
2016-12-31	CN¥2.98 Billion ≈ $435.39 Million	CN¥139.94 Million ≈ $20.48 Million	0.047x	-63.22%
2015-12-31	CN¥1.42 Billion ≈ $207.70 Million	CN¥181.52 Million ≈ $26.56 Million	0.128x	-64.12%
2014-12-31	CN¥595.76 Million ≈ $87.18 Million	CN¥212.35 Million ≈ $31.07 Million	0.356x	+14.22%
2013-12-31	CN¥502.20 Million ≈ $73.49 Million	CN¥156.71 Million ≈ $22.93 Million	0.312x	+64.60%
2012-12-31	CN¥425.82 Million ≈ $62.31 Million	CN¥80.73 Million ≈ $11.81 Million	0.190x	-45.08%
2011-12-31	CN¥356.28 Million ≈ $52.14 Million	CN¥122.99 Million ≈ $18.00 Million	0.345x	--

About Yifeng Pharmacy

SHG:603939 China Pharmaceutical Retailers

Market Cap

$4.12 Billion

CN¥28.13 Billion CNY

Market Cap Rank

#4083 Global

#692 in China

Share Price

CN¥23.20

Change (1 day)

-0.98%

52-Week Range

CN¥21.12 - CN¥28.06

All Time High

CN¥967.78